Results 341 to 350 of about 341,426 (407)

Intranasal monoclonal antibodies to mugwort pollen reduce allergic inflammation in a mouse model of allergic rhinitis and asthma. [PDF]

Front Immunol
Tabynov K, Nedushenko I, Tailakova E, Sergazina A, Bolatbekov T, Fomin G, Nurpeissov T, Vaghasiya U, Petrovsky N, Demyanov A, Lebedin Y, Tabynov K.   +11 more
europepmc   +1 more source

Reduced Type‐I Interferon by Plasmacytoid Dendritic Cells and Asthma in School‐Aged Children

Allergy, EarlyView.
Low type‐I interferon response to in vitro stimulation of plasmacytoid dendritic cells (pDC) with a TLR7/8 agonist (R848) is associated with current asthma in school‐aged children. Low type‐I interferon response is associated with increased level of atopy but appears to have limited impact on early life viral infection susceptibility.
Isabelle Coenen, Anya C. Jones, Alice A. White, Mari Takashima, Wen Ray Lee, Matthew D. Wong, Dwan Vilcins, Ulrich Kadolsky, Ali Sadiq Cheema, Alka Saxena, Anthony Bosco, Keith Grimwood, Peter D. Sly, Deborah H. Strickland, Jonatan Leffler   +14 more
wiley   +1 more source

Anti-IgE therapy versus allergen-specific immunotherapy for food allergy: weighing the pros and cons. [PDF]

Front Immunol
Kulis MD, Humphrey JR, Krempski JW, Kim EH, Smeekens JM.   +4 more
europepmc   +1 more source

Natural History of Airway Hyperresponsiveness and Its Association With Asthma Traits

Allergy, EarlyView.
AHR improves in most children over adolescence when its relationship with asthma changes. AHR is better at ruling out asthma in children, while it is superior at ruling in asthma in young adults. Age should be considered when interpreting AHR, and different cutoffs might be required for children and adults.
Sophie Carra, Hongmei Zhang, Ramesh J. Kurukulaaratchy, Syed Hasan Arshad   +3 more
wiley   +1 more source

Clinical outcomes of allergen immunotherapy in children in Latin America: Treatment with polymerized allergen extracts of <i>Dermatophagoides pteronyssinus</i> and <i>Dermatophagoides farinae</i>. [PDF]

World Allergy Organ J
Cardona-Villa R, Del Pozo S, Uribe-García S, Calvo-Betancur VD, Fernández-Caldas E, Sánchez J.   +5 more
europepmc   +1 more source

Alert Card for Patients on Biologicals and Immunosuppressives: An EAACI Position Paper

Allergy, EarlyView.
Adam Chaker, Paula Kauppi, Sevim Bavbek, Apostolos Bossios, Alexia Chatzipetrou, Davide Firinu, Barbara Rogala, Andrea Matucci, Alessandra Vultaggio, Petr Panzner, Wojciech Feleszko, Ron Eliashar, Ioanna Agache, Ludger Klimek, Maria Torres, Oliver Pfaar, Oscar Palomares, Mohamed Shamji, Thomas Eiwegger, Antonios G. A. Kolios   +19 more
wiley   +1 more source

B-cell epitope prediction for developing allergy vaccines and their companion immunodiagnostics. [PDF]

Front Immunol
Falcon RMG, Fahrenbach SU, Ortiz LCE, Caoili SEC.   +3 more
europepmc   +1 more source

COVID‐19 Pandemic and Decrease in New‐Onset Asthma Incidence: National Data From Korea

Allergy, EarlyView.
Sang Hyuk Kim, Seung‐Hun You, Ju Won Lee, Eunji Kim, Youlim Kim, Hyun Lee, Sun‐Young Jung, Ji‐Yong Moon   +7 more
wiley   +1 more source

T Cell Subsets Are Altered Off Season in Patients With Allergic Rhinitis

Allergy, EarlyView.
Maryam Jafari, Eric Hjalmarsson, Eirini Paziou, Marianne Petro, Agnetha Karlsson, Ola Winqvist, Susanna Kumlien Georén, Lars‐Olaf Cardell   +7 more
wiley   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Recombinant allergens/ allergen standardization

Current Allergy and Asthma Reports, 2001
Recombinant allergens are genetically engineered isoforms representing allergen molecules from allergen extracts. Immunologic responses of allergic patients toward allergen extracts define the major allergens. For the average allergic patient, the diagnostic sensitivity and treatment efficacy correlate with the concentration of major allergen ...
Jørgen Nedergaard Larsen, Henning Løwenstein   +1 more
openaire   +3 more sources